CMCM
Cheetah Mobile Inc.
CMCM trails on the overall score without a compensating advantage in the available component scores.
TMUS
T-Mobile US, Inc.
TMUS has the edge over CMCM overall, supported by stronger valuation and stronger modeled upside.
CMCM Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Strong |
CMCM's balance sheet is currently strong, and its revenue is stable, but its profitability and cash flow are under pressure.
TMUS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Strong |
TMUS's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
CMCM PE Valuation
CMCM has no meaningful PE right now: it lost money over the past year.
TMUS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 13x | $171 | — |
| Current | 16x | $171 | — |
| Cheap | 21x | $218 | +27% |
| Fair | 26x | $274 | +60% |
| Expensive | 56x | $581 | +240% |
Historical ranges are pointers, not guarantees.
TMUS's PE is in its cheap range at 16x. If earnings grow as analysts expect, today's price would be 13x next year's earnings.
CMCM Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Stable | |
| Stable | |
| Stable | |
| Limited | |
| High |
Analysts expect CMCM's earnings, revenue and profitability to hold roughly steady.
TMUS Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
TMUS has the edge over CMCM on the outlook, with more favorable earnings and revenue expectations.
CMCM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$76.24 | +$41.87 |
| Q1 2026 | -$59.05 | +$84.04 |
| Q4 2025 | -$63.18 | +$91.17 |
| Q3 2025 | -$109.10 | -$5.40 |
| Q2 2025 | -$118.11 | +$14.85 |
| Q1 2025 | -$143.09 | -$5.32 |
| Q4 2024 | -$154.35 | -$0.83 |
| Q3 2024 | -$103.70 | +$67.16 |
CMCM is still losing money, but far less than before: $76.24 per share over the past year, against $188.19 at its worst in mid-2023.
TMUS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.49 | +30% |
| Q3 2026 | $10.37 | -0.2% |
| Q2 2026 | $9.56 | -9.7% |
| Q1 2026 | $9.41 | -8.1% |
| Q4 2025 | $9.72 | +0.6% |
| Q3 2025 | $10.39 | +18% |
| Q2 2025 | $10.59 | +33% |
| Q1 2025 | $10.24 | +39% |
| Q4 2024 | $9.66 | +39% |
TMUS has the edge over CMCM on earnings quality, reporting a profit while its opponent remains loss making.
CMCM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $39.9M | -9.9% |
| Q1 2026 | $38.9M | 0% |
| Q4 2025 | $46.3M | +30% |
| Q3 2025 | $43.1M | +50% |
| Q2 2025 | $44.3M | +58% |
| Q1 2025 | $38.9M | +36% |
| Q4 2024 | $35.6M | +42% |
| Q3 2024 | $28.8M | +17% |
CMCM's revenue is growing: $40M last quarter, down 9.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -13% | -8.9 points |
| Q1 2026 | -11% | -0.7 points |
| Q4 2025 | -34% | -11 points |
| Q3 2025 | 1.4% | +39 points |
| Q2 2025 | -3.8% | +38 points |
| Q1 2025 | -10% | +32 points |
| Q4 2024 | -23% | +14 points |
| Q3 2024 | -37% | -13 points |
CMCM's operating margin was −13% last quarter, down 8.9 points from the same quarter a year ago.
TMUS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $23.6B | +7.4% |
| Q2 2026 | $22.8B | +7.9% |
| Q1 2026 | $23.1B | +11% |
| Q4 2025 | $24.3B | +11% |
| Q3 2025 | $22B | +8.9% |
| Q2 2025 | $21.1B | +6.9% |
| Q1 2025 | $20.9B | +6.6% |
| Q4 2024 | $21.9B | +6.8% |
TMUS's revenue has grown year over year for 10 quarters in a row: $23.6B last quarter, up 7.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 24% | +3.4 points |
| Q2 2026 | 24% | -0.6 points |
| Q1 2026 | 19% | -3.5 points |
| Q4 2025 | 15% | -5.6 points |
| Q3 2025 | 21% | -3.2 points |
| Q2 2025 | 25% | +1.3 points |
| Q1 2025 | 23% | +2.6 points |
| Q4 2024 | 21% | +4 points |
TMUS has the edge over CMCM on profitability, with a higher operating margin.
CMCM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | $0 |
| Q1 2026 | $0 | $0 |
| Q4 2025 | -$27.8M | -$27.8M |
| Q3 2025 | $0 | $0 |
| Q2 2025 | $0 | $0 |
| Q1 2025 | $0 | $0 |
| Q4 2024 | $0 | $0 |
| Q3 2024 | $0 | $0 |
CMCM's free cash flow was −$28M over the past year, against $0 the year before.
TMUS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $5.1B | +5.3% |
| Q2 2026 | $4.8B | +4.4% |
| Q1 2026 | $4.6B | +4.6% |
| Q4 2025 | $4.2B | +25% |
| Q3 2025 | $4.8B | +15% |
| Q2 2025 | $4.6B | +32% |
| Q1 2025 | $4.4B | +79% |
| Q4 2024 | $3.3B | +2% |
TMUS has the edge over CMCM on cash generation, producing positive trailing cash flow while its opponent burns cash.
CMCM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +765 shares |
| 1 year | +2.3% | +14.2K shares |
| 3 years | +7% | +40.7K shares |
| 5 years | +8.3% | +47.9K shares |
| Available history | +13% | +71.1K shares |
CMCM has 621,551 diluted shares, up 2.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
CMCM hasn't bought back shares in the past year.
TMUS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -10.8M shares |
| 1 year | -4.9% | -55M shares |
| 3 years | -8.8% | -103M shares |
| 5 years | -15% | -182M shares |
| Available history | +24% | +207M shares |
TMUS has the edge over CMCM on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $2.4B |
| Q2 2026 | $2.3B |
| Q1 2026 | $4.8B |
| Q4 2025 | $2.4B |
| Q3 2025 | $2.5B |
| Q2 2025 | $2.6B |
| Q1 2025 | $2.5B |
| Q4 2024 | $4.7B |
TMUS spent $12B buying back its own shares over the past year, down 1.7% from the year before.
CMCM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -168.5x | Net Cash |
| Q4 2025 | -159.4x | Net Cash |
CMCM has more cash than debt.
TMUS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.0x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | 2.5x | Moderate |
| Q3 2025 | 0.1x | Very low |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | 2.4x | Moderate |
TMUS's net debt is less than a year of its operating earnings (EBITDA).
CMCM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 29.9 | Oversold |
| Stochastic | 18.7 | Oversold |
CMCM's weekly RSI is 30 (oversold) and its Stochastic is 19 (oversold).
TMUS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.9 | Neutral |
| Stochastic | 42.1 | Neutral |
TMUS's weekly RSI is 48 (neutral) and its Stochastic is 42 (neutral).
CMCM PE vs Communication Services Sector
CMCM has no meaningful PE right now: it lost money over the past year.
TMUS PE vs Communication Services Sector
| Metric | TMUS | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 16x | Same PE |
| PE % | 1 | 26 | 25 pts below |
TMUS is trading at 16x earnings, in line with the Communication Services sector's median of 16x.
CMCM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.44 | 7.8% below |
| 20 week MA | $2.83 | 20% below |
| 50 week MA | $4.57 | 51% below |
| 100 week MA | $4.99 | 55% below |
| 200 week MA | $4.01 | 44% below |
CMCM is in a downtrend: it's below all five of its weekly moving averages, and 44% below its 200-week average.
TMUS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $159.1 | 7.5% above |
| 20 week MA | $172.0 | 0.5% below |
| 50 week MA | $187.8 | 8.9% below |
| 100 week MA | $212.9 | 20% below |
| 200 week MA | $188.7 | 9.4% below |
TMUS has the edge over CMCM on trend strength, trading above more of its moving averages.
CMCM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $17.7 | $9.65 | -45% |
| 2021 | $9.65 | $6.20 | -36% |
| 2022 | $6.20 | $1.91 | -69% |
| 2023 | $1.91 | $2.28 | +19% |
| 2024 | $2.28 | $4.90 | +115% |
| 2025 | $4.90 | $6.34 | +29% |
| 2026 YTD | $6.34 | $2.25 | -65% |
CMCM's yearly returns have swung widely, from +115% in 2024 to −69% in 2022. It's down 65% so far in 2026.
TMUS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $77.2 | $132.9 | +72% |
| 2021 | $132.9 | $119.9 | -9.8% |
| 2022 | $119.9 | $140.0 | +17% |
| 2023 | $140.0 | $160.3 | +15% |
| 2024 | $160.3 | $223.0 | +39% |
| 2025 | $223.0 | $201.0 | -9.9% |
| 2026 YTD | $201.0 | $171.0 | -15% |
TMUS has the edge over CMCM on returns for 2026, with the stronger performance.